CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.
Human CYP2B6 has been thought to account for a minor portion (<1%) of total hepatic cytochrome P450 (CYP) content and to have a minor function in human drug metabolism. Recent studies, however, indicate that the average relative contribution of CYP2B6 to total hepatic CYP content ranges from 2% to 10%. An increased interest in CYP2B6 research has been stimulated by the identification of an ever-increasing substrate list for this enzyme, polymorphic and ethnic variations in expression levels, and evidence for cross-regulation with CYP3A4, UGT1A1 and several hepatic drug transporters by the nuclear receptors pregnane X receptor and constitutive androstane receptor. Moreover, 20- to 250-fold interindividual variation in CYP2B6 expression has been demonstrated, presumably due to transcriptional regulation and polymorphisms. These individual differences may result in variable systemic exposure to drugs metabolized by CYP2B6, including the antineoplastics cyclophosphamide and ifosfamide, the antiretrovirals nevirapine and efavirenz, the anesthetics propofol and ketamine, the synthetic opioid methadone, and the anti-Parkinsonian selegiline. The potential clinical significance of CYP2B6 further enforces the need for a comprehensive review of this xenobiotic metabolizing enzyme. This communication summarizes recent advances in our understanding of this traditionally neglected enzyme and provides an overall picture of CYP2B6 with respect to expression, localization, substrate-specificity, inhibition, regulation, polymorphisms and clinical significance. Emphasis is given to nuclear receptor mediated transcriptional regulation, genetic polymorphisms, and their clinical significance.
Wang
Hongbing
H
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, 20 Penn Street, Baltimore, MD 21201, USA. hwang@rx.umaryland.edu
Tompkins
Leslie M
LM
D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D065702:Cytochrome P-450 CYP2B6; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D010089:Oxidoreductases, N-Demethylating / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D020218:Response Elements
D018160:Receptors, Cytoplasmic and Nuclear; D001189:Aryl Hydrocarbon Hydroxylases; C585599:CYP2B6 protein, human; D065702:Cytochrome P-450 CYP2B6; D010089:Oxidoreductases, N-Demethylating
Nucleic Acids Res. 1990 Jul 25;18(14):4237-42
2377462
Drug Metab Dispos. 1993 Nov-Dec;21(6):1048-56
7905383
Breast Cancer Res Treat. 1993;26 Suppl:S11-7
8400329
Mol Pharmacol. 2008 Apr;73(4):1122-33
18212249
Pharmacogenomics. 2008 Jan;9(1):71-83
18154449
J Pharmacol Exp Ther. 2007 Jan;320(1):72-80
17041008
Pharmacogenetics. 1997 Oct;7(5):381-90
9352574
Drug Metab Dispos. 2000 Feb;28(2):110-2
10640505
Pharmacogenet Genomics. 2007 Jun;17(6):431-45
17502835
Clin Infect Dis. 2006 Feb 1;42(3):408-10
16392090
Nature. 2000 Oct 19;407(6806):920-3
11057673
Comp Biochem Physiol C Toxicol Pharmacol. 2002 Apr;131(4):501-10
11976065
Drug Metab Dispos. 2000 Oct;28(10):1222-30
10997944
Mol Cell Biol. 1999 Sep;19(9):6318-22
10454578
Biochem Biophys Res Commun. 2006 Aug 25;347(2):485-95
16828057
Pharmacogenetics. 2004 Jan;14(1):1-18
15128046
J Clin Pharmacol. 2008 Apr;48(4):464-74
18287571
Xenobiotica. 1996 Nov;26(11):1155-66
8948091
Drug Metab Dispos. 2004 Sep;32(9):930-6
15319333
Clin Pharmacol Ther. 2003 Jul;74(1):32-43
12844133
Xenobiotica. 1999 Feb;29(2):187-93
10199594
J Biol Chem. 2001 May 4;276(18):14581-7
11297522
Proc Natl Acad Sci U S A. 1983 Jul;80(13):3958-62
6306654
Eur J Pharm Sci. 2001 Jul;13(4):343-68
11408150
J Biol Chem. 2008 Apr 18;283(16):10425-32
18303024
Drug Metab Dispos. 2003 Apr;31(4):439-46
12642470
Drug Metab Dispos. 1999 Nov;27(11):1309-18
10534317
Clin Pharmacokinet. 2003;42(15):1331-57
14674787
Mol Cell. 2004 Dec 22;16(6):893-905
15610733
Mol Pharmacol. 2006 Dec;70(6):1925-34
16988011
Cancer Lett. 2008 Jan 18;259(1):1-15
18053638
Mol Pharmacol. 2002 Sep;62(3):638-46
12181440
Curr Drug Metab. 2005 Aug;6(4):369-83
16101575
Clin Infect Dis. 2006 Feb 1;42(3):401-7
16392089
Mol Cell Biol. 1998 Oct;18(10):5652-8
9742082
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1045-50
17213310
Toxicology. 1998 Nov 2;131(1):9-20
9881931
Pharmacogenetics. 1996 Feb;6(1):1-42
8845856
Proc Natl Acad Sci U S A. 1982 May;79(9):2793-7
6953431
J Biol Chem. 2001 Oct 12;276(41):37739-42
11459851
Neuropharmacology. 2003 Jul;45(1):122-32
12814665
Biol Pharm Bull. 2000 Apr;23(4):498-501
10784435
Curr Drug Metab. 2003 Dec;4(6):515-25
14683479
Clin Pharmacol Ther. 2007 May;81(5):719-28
17329992
J Biochem Mol Toxicol. 2005;19(2):96-108
15849716
Ann Hum Genet. 1985 Oct;49(4):267-74
3000277
Biochem J. 1992 Jan 15;281 ( Pt 2):359-68
1736885
Clin Infect Dis. 2007 Nov 1;45(9):1230-7
17918089
Mol Cell Biol. 2000 May;20(9):2951-8
10757780
Pharmacogenetics. 2001 Jul;11(5):399-415
11470993
Pharmacogenet Genomics. 2005 Jan;15(1):1-5
15864119
Mol Pharmacol. 2000 Dec;58(6):1441-50
11093784
Br J Clin Pharmacol. 1999 Oct;48(4):528-35
10583023
Biochem Pharmacol. 2001 Jul 15;62(2):161-9
11389874
J Clin Invest. 1992 Nov;90(5):1871-8
1430211
Drug Metab Rev. 1999 Aug;31(3):719-54
10461547
J Biol Chem. 2000 May 19;275(20):15122-7
10748001
Drug Metab Dispos. 2002 Dec;30(12):1400-5
12433810
J Biochem Mol Toxicol. 2007;21(2):76-80
17427179
J Biol Chem. 2005 Feb 4;280(5):3458-66
15563456
Drug Metab Dispos. 2002 Jul;30(7):814-22
12065440
Drug Metab Dispos. 2003 May;31(5):620-30
12695351
Rinsho Ketsueki. 2002 Jun;43(6):482-7
12134706
Drug Metab Dispos. 2007 Nov;35(11):2053-9
17682072
Pharmacogenomics. 2007 Jun;8(6):547-58
17559344
Pharmacogenet Genomics. 2005 Dec;15(12):861-73
16272958
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42
17786128
Drug Metab Dispos. 1997 Aug;25(8):985-93
9280407
Drug Metab Rev. 2002 Feb-May;34(1-2):83-448
11996015
Nucleic Acids Res. 2003 Jun 15;31(12):3194-207
12799447
J Biol Chem. 2004 Jul 9;279(28):29295-301
15123723
J Pharmacol Exp Ther. 2008 Apr;325(1):284-92
18171905
Mol Pharmacol. 2002 Sep;62(3):737-46
12181452
Curr Drug Metab. 2003 Feb;4(1):59-72
12570746
Clin Pharmacokinet. 2005;44(11):1135-64
16231966
Pharm Res. 2006 Sep;23(9):1983-90
16951995
Gene. 1995 Jun 9;158(2):263-8
7607552
Annu Rev Pharmacol Toxicol. 2001;41:123-43
11264453
Br J Clin Pharmacol. 2007 Sep;64(3):391-5
17391322
Chirality. 2004 Jan;16(1):36-44
14628297
AIDS. 2004 Dec 3;18(18):2391-400
15622315
Mol Pharmacol. 2005 May;67(5):1772-82
15722458
Cancer Res. 1993 Dec 1;53(23):5629-37
8242617
Mol Genet Metab. 2005 Sep-Oct;86(1-2):314-9
15990349
Eur J Pharm Sci. 2005 Jan;24(1):123-32
15626586
Mol Pharmacol. 2005 Jun;67(6):1954-65
15761118
Cell Biol Toxicol. 2007 Mar;23(2):63-73
16964586
Eur J Clin Pharmacol. 2006 Jul;62(7):585-6
16770645
Anesthesiology. 1995 Jan;82(1):214-20
7832304
Pharmacogenomics J. 2005;5(1):6-13
15492763
Pediatr Nephrol. 2005 Jul;20(7):872-85
15875221
J Biol Chem. 2005 Feb 11;280(6):4367-73
15572372
Mol Pharmacol. 2005 Nov;68(5):1239-53
16099843
Nature. 1998 Oct 8;395(6702):612-5
9783588
Drug Metab Dispos. 1994 Nov-Dec;22(6):937-46
7895613
Toxicol Sci. 2006 Dec;94(2):261-71
16945988
J Biochem Mol Toxicol. 1998;12(1):3-9
9414482
Anesthesiology. 2001 Jan;94(1):110-9
11135730
Drug Metab Dispos. 2001 Jun;29(6):887-90
11353758
J Biol Chem. 2001 Apr 20;276(16):12822-6
11278292
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4156-61
12644704
Eur J Pharm Sci. 2006 Jan;27(1):54-61
16183265
Drug Metab Dispos. 2001 Jan;29(1):36-40
11124227
Drug Metab Dispos. 2002 Dec;30(12):1329-36
12433799
Biochem Soc Trans. 1990 Dec;18(6):1202
2088865
J Biol Chem. 2003 Apr 18;278(16):14146-52
12571232
J Pharmacol Exp Ther. 1994 Jul;270(1):414-23
8035341
Mol Endocrinol. 2004 Jul;18(7):1589-98
14988430
Curr HIV/AIDS Rep. 2006 Jul;3(2):53-8
16608660
Science. 2001 Jun 22;292(5525):2329-33
11408620
J Biol Chem. 1996 Apr 19;271(16):9746-53
8621653
Ann Hum Genet. 1988 May;52(2):129-35
3248006
Clin Pharmacol Ther. 2006 Jul;80(1):75-84
16815319
Biochem Pharmacol. 2000 Apr 15;59(8):961-72
10692561
J Biol Chem. 1996 Sep 27;271(39):23725-8
8798596
Biochemistry. 1989 Sep 5;28(18):7340-8
2573390
Biochem Pharmacol. 1993 Mar 24;45(6):1251-9
8466546
Hum Genomics. 2005 Sep;2(3):196-201
16197738
Mol Pharmacol. 1993 Oct;44(4):775-83
8232228
J Biochem Mol Toxicol. 2000;14(4):177-88
10789495
Pharmacogenomics. 2007 Jul;8(7):743-59
17638512
Cancer Res. 2004 Jan 1;64(1):292-303
14729637
Biol Pharm Bull. 2005 Sep;28(9):1711-6
16141545
Drug Metab Dispos. 1999 Dec;27(12):1488-95
10570031
Toxicology. 1996 Apr 30;108(3):185-90
8658537
Mol Pharmacol. 2003 Jul;64(1):160-9
12815172
Arch Biochem Biophys. 2000 Apr 1;376(1):206-16
10729207
Br J Clin Pharmacol. 2002 Aug;54(2):157-67
12207635
J Biol Chem. 1999 Mar 5;274(10):6043-6
10037683
Clin Pharmacol Ther. 1996 Jun;59(6):613-23
8681486
Hepatology. 2001 May;33(5):1232-8
11343253
Mol Pharmacol. 2001 Sep;60(3):427-31
11502872
Carcinogenesis. 1994 Jan;15(1):5-9
8293548
Biochem Biophys Res Commun. 2004 Jul 9;319(4):1322-6
15194512
Drug Metab Dispos. 2004 Jan;32(1):35-42
14709618
J Biol Chem. 2006 Sep 8;281(36):26540-51
16825189
Clin Pharmacol Ther. 2004 Sep;76(3):250-69
15371986
Alcohol Clin Exp Res. 1999 Jun;23(6):991-1007
10397283
Mol Cell. 2004 Dec 22;16(6):907-17
15610734
Biochem Biophys Res Commun. 2000 Oct 14;277(1):1-6
11027630
Drug Metab Dispos. 1999 Apr;27(4):517-25
10101147
Annu Rev Pharmacol Toxicol. 2003;43:149-73
12171978
Hepatology. 2004 Oct;40(4):951-60
15382119
Drug Metab Dispos. 2004 Jun;32(6):626-31
15155554
Drug Metab Dispos. 1999 Dec;27(12):1429-33
10570024
J Pharmacol Exp Ther. 2004 Oct;311(1):34-43
15190123
J Clin Pharmacol. 2006 Dec;46(12):1426-38
17101742
Anesthesiology. 1995 Mar;82(3):689-99
7879937
J Pharmacol Exp Ther. 2006 Jun;317(3):1200-9
16513849
Drug Metab Dispos. 2001 Oct;29(10):1325-31
11560876
J Biol Chem. 1983 Jul 10;258(13):8081-5
6408085
Biochem J. 2006 Aug 15;398(1):125-33
16623664
Biochem Pharmacol. 1998 May 15;55(10):1633-40
9633999
Pharmacol Ther. 2007 Feb;113(2):420-8
17157385
Drug Metab Dispos. 1999 Jun;27(6):655-66
10348794
Drug Metab Dispos. 2002 Jul;30(7):853-8
12065445
Drug Metab Dispos. 2004 Mar;32(3):348-58
14977870
Neuropharmacology. 2006 Mar;50(4):441-50
16309716
Clin Pharmacol Ther. 2007 Apr;81(4):557-66
17235330
Br J Clin Pharmacol. 2001 Mar;51(3):281-5
11298076
Cell Mol Life Sci. 2001 May;58(5-6):737-47
11437235
Xenobiotica. 2003 Jan;33(1):13-25
12519691
Pharmacogenetics. 2004 Apr;14(4):225-38
15083067
Mol Pharmacol. 1998 Apr;53(4):597-601
9547348
J Pharmacol Exp Ther. 1998 Sep;286(3):1253-9
9732386
AIDS. 2001 Jan 5;15(1):71-5
11192870
Steroids. 2007 Mar;72(3):231-46
17284330
Biochem Pharmacol. 2001 Sep 15;62(6):777-86
11551524
J Pharmacol Exp Ther. 2003 Jul;306(1):287-300
12676886
J Biol Chem. 2003 May 9;278(19):17277-83
12611900
Drug Metab Dispos. 2000 Oct;28(10):1176-83
10997936
J Pharmacol Exp Ther. 2003 Dec;307(3):906-22
14551287
Carcinogenesis. 1997 Jan;18(1):207-14
9054608
Drug Metab Dispos. 2003 Sep;31(9):1093-102
12920164
Biochem Pharmacol. 1996 Apr 26;51(8):1041-50
8866826
Curr Drug Metab. 2005 Aug;6(4):329-39
16101572
J Biol Chem. 1998 Apr 3;273(14):8528-36
9525968
J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):551-6
16044006
Curr Drug Metab. 2006 May;7(4):397-409
16724929
Pharmacogenetics. 1999 Jun;9(3):295-306
10471061
Drug Metab Dispos. 2002 Sep;30(9):1035-42
12167570
Pharmacogenomics J. 2003;3(1):53-61
12629583
Drug Metab Dispos. 2001 Nov;29(11):1480-4
11602525
Drug Metab Dispos. 1997 Dec;25(12):1383-8
9394028